Companies in the Immunoglobulins Market are facing issues in keeping their production facilities fully functional due to shortage of staff and resources amidst the COVID-19 (Coronavirus) outbreak. Get a hands-on over key drivers and threats to the Immunoglobulins Market to make your company future-ready post the pandemic. Avails out reports for exciting prices to learn new opportunities that companies can capitalize on during and after the Coronavirus crisis.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4788
The global immunoglobulins market is set to grow impressively at a CAGR of 7.0% during the forecast period (2020-2026). The market is poised to reach a valuation of US$ 20.7 Bn by 2026-end. Upsurge in immunological diseases has prompted individuals to seek advanced medical treatment, thus augmenting the immunoglobulins market share.
The Immune Deficiency Foundation (IDF) estimates that approximately 83 people per 100,000 in North America suffer from primary immunodeficiency, leading to the prevalence of such diseases. In response, off-label indications, intravenous and subcutaneous immunoglobulins has risen considerably. Rising geriatric population pool shall also steer market growth. The ongoing COVID-19 pandemic is anticipated to provide leverage to the immunoglobulins market as healthcare providers are increasingly researching ways to apply immunoglobulins to treat the disease.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4788
Global Immunoglobulins Market Segmentation
Fact.MR has studied the global immunoglobulins market with detailed segmentation on the basis of Application, Route of Administration, End-user and key regions.
|Application||Route of Administration||End-user||Key Regions|
|Middle East & Africa (MEA)|
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4788/S
“Several key players have made credible investments in research and development programs for IVIG, SCIG and IMIG applications. Promising results in novel clinical applications are poised to generate lucrative opportunities for the global immunoglobulins market,” concludes a Fact.MR analyst.
Global Immunoglobulins Market: Competitive Landscape
The global immunoglobulins consist of the following key players such as Grifols S.A, Shire, CSL Behring, Octapharma, Kedrion Biopharma Inc., China Biologic Products Holdings, Inc., Biotest AG, Sanquin and LFB SA. Most of these companies concentrate on molecular immunoglobulins indications and subsequent development of pipeline products.
Grifols S.A, for instance, manufactures Gamunex C and Flebogamma Intravenous immunoglobulin products. Gamunex C is a sterilized solution made from human plasma which contains antibodies to treat primary immunodeficiency. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency and Wiskott – Aldrich syndrome.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=4788
Likewise, CSL Behring produces subcutaneous immunoglobulin products such as Privigen, Evogam and Beriglobin P. Berigloin P which are presented in the form of an injection containing excipients of glycine, sodium chloride, hydrochloric acid or sodium hydroxide and water.
Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape
Ultrasound Systems Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031:https://www.factmr.com/report/60/ultrasound-systems-market
Blood Thawing System Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/blood-thawing-system-market
Radiation Proctitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/5281/radiation-proctitis-treatment-market
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583